FR3036956B1 - Methode de stimulation de la synthese de l'acide hyaluronique - Google Patents

Methode de stimulation de la synthese de l'acide hyaluronique Download PDF

Info

Publication number
FR3036956B1
FR3036956B1 FR1555116A FR1555116A FR3036956B1 FR 3036956 B1 FR3036956 B1 FR 3036956B1 FR 1555116 A FR1555116 A FR 1555116A FR 1555116 A FR1555116 A FR 1555116A FR 3036956 B1 FR3036956 B1 FR 3036956B1
Authority
FR
France
Prior art keywords
synthesis
hyaluronic acid
stimulating
expression
decrease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1555116A
Other languages
English (en)
Other versions
FR3036956A1 (fr
Inventor
Bertrand Thomas
Mathilde THOMAS
David Sinclair
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Caudalie Ip Ltd
Harvard College
Original Assignee
Caudalie Ip Ltd
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caudalie Ip Ltd, Harvard College filed Critical Caudalie Ip Ltd
Priority to FR1555116A priority Critical patent/FR3036956B1/fr
Publication of FR3036956A1 publication Critical patent/FR3036956A1/fr
Application granted granted Critical
Publication of FR3036956B1 publication Critical patent/FR3036956B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compositions permettant la stimulation de la synthèse de l'acide hyaluronique via une augmentation de l'expression de has-2 et leur utilisation dans le traitement des affections liées à une diminution de la synthèse de l'acide hyaluronique.
FR1555116A 2015-06-05 2015-06-05 Methode de stimulation de la synthese de l'acide hyaluronique Active FR3036956B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1555116A FR3036956B1 (fr) 2015-06-05 2015-06-05 Methode de stimulation de la synthese de l'acide hyaluronique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1555116A FR3036956B1 (fr) 2015-06-05 2015-06-05 Methode de stimulation de la synthese de l'acide hyaluronique
FR1555116 2015-06-05

Publications (2)

Publication Number Publication Date
FR3036956A1 FR3036956A1 (fr) 2016-12-09
FR3036956B1 true FR3036956B1 (fr) 2019-12-20

Family

ID=54329647

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1555116A Active FR3036956B1 (fr) 2015-06-05 2015-06-05 Methode de stimulation de la synthese de l'acide hyaluronique

Country Status (1)

Country Link
FR (1) FR3036956B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019111688A1 (de) * 2019-05-06 2020-11-12 Bhi Beauty & Health Investment Group Management Gmbh Kosmetische Zubereitung
WO2021254637A1 (fr) 2020-06-19 2021-12-23 Tomcat International Limited Association d'ingrédients actifs naturels pour lutter contre le vieillissement de la peau
CN113813202A (zh) * 2020-06-19 2021-12-21 汤姆凯特国际有限公司 用于对抗皮肤老化的天然活性成分的联合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777186B1 (fr) * 1998-04-10 2001-03-09 Oreal Utilisation d'au moins un hydroxystilbene dans une composition raffermissante
ITMI20051416A1 (it) * 2005-07-22 2007-01-23 Beauty Farm Del Sorriso S R L Composizioni cosmetiche contenenti acido ialuronico e colostro
KR100927579B1 (ko) * 2006-12-13 2009-11-23 주식회사 엘지생명과학 히아루론산 및/또는 그것의 염을 함유하는 아토피성피부염의 개선 및 치료를 위한 조성물
ES2378028B1 (es) * 2012-02-22 2013-02-18 Ignacio Umbert Millet Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes

Also Published As

Publication number Publication date
FR3036956A1 (fr) 2016-12-09

Similar Documents

Publication Publication Date Title
EA201890725A1 (ru) Агонисты фарнезоидного х-рецептора и их применение
EA201800367A1 (ru) Способы лечения болезни хантингтона
EA201792047A1 (ru) Новые соединения
GEP20217328B (en) Bispecific molecules having immunoreactivity with pd-1 and ctla-4, and methods of use thereof
EA201990665A1 (ru) Регуляторы hpk1 на основе производных пиразолопиридина и их применение для лечения рака
EA201792354A1 (ru) Композиции обетихолевой кислоты и способы применения
EA201790273A1 (ru) Флагеллиновые композиции и их применение
BR112017024384A2 (pt) bactérias modificadas para reduzir hiperfenilalaninemia
EA201890204A1 (ru) Антибактериальные соединения
EA201990043A1 (ru) Антибактериальные соединения
EA201691940A1 (ru) Новые соединения
EA202090948A1 (ru) Иммуномодуляция
EA201691447A1 (ru) 2-амино-3,5,5-трифтор-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1 для лечения болезни альцгеймера
EA201691582A1 (ru) Новые фармацевтические препараты
TR201908994T4 (tr) Farmasötik bileşimler.
TR201901886T4 (tr) DNA-PK inhibitörleri.
EA201790817A1 (ru) 2-амино-3,5-дифтор-3,6-диметил-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы bace1 для лечения болезни альцгеймера
EA201691845A1 (ru) Фармацевтические композиции терапевтически активных соединений
EA201890245A1 (ru) Замещенные 4-азаиндолы и их применение в качестве модуляторов рецептора glun2b
MX2016002241A (es) Alcoholes de alquinilo y metodos de uso.
EA201600589A1 (ru) Ингибиторы диацилглицеринацилтрансферазы 2 для применения в лечении метаболических и связанных с метаболизмом расстройств
EA201691844A1 (ru) Фармацевтические композиции терапевтически активных соединений
EA201790818A1 (ru) 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы bace1
EA201390826A1 (ru) ПИРИМИДИНОНОВЫЕ СОЕДИНЕНИЯ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ИЛИ СОСТОЯНИЙ, ОПОСРЕДОВАННЫХ Lp-PLA
EA201790519A1 (ru) Терапевтические соединения в качестве ингибиторов рецептора орексина-1

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20161209

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10